bpc-157 axonal regeneration bpc 157 spinal cord injury for spine Novel Therapeutic Effects in Rat Injuries: Recovery of the bpc-157 nerve evidence Stable Spinal Cord Injury in Rat – bpc 157 route of administration

Keep the vials refrigerated when not in use, and do not allow them to freeze

It is not available as a licensed medicine through the NHS or any regulated UK pharmacy

TB-500's parent compound (Thymosin Beta-4) has more human clinical exposure through RegeneRx trials

All nine patients serum vitamin B12 levels improved (mean increase, 117.4 pg/mL

Per week: 14 swabs (2/day) 4 weeks: 56 swabs recommend 1 100-count box 6 weeks: 84 swabs recommend 1 100-count box 8 weeks: 112 swabs recommend 2 100-count boxes Protocol Overview Concise summary of the once-daily regimen

Typical TB500 Dosing Schedule Loading Phase (Weeks 14): Dosage: 48 mg per week Frequency: Split into 2 injections per week (e.g., Monday/Thursday) Goal: Rapid saturation of soft tissue to initiate repair Maintenance Phase (Weeks 58 or longer): Dosage: 26 mg per month Frequency: 1 injection every 714 days Goal: Support long-term recovery and tissue integrity Users typically adjust their dose based on: Injury severity Body weight Co-administration with BPC157 or other peptides Note: These guidelines are based on research chemical protocols and anecdotal data